Homologous human and murine antisense oligonucleotides targeting stat6: Functional effects on germline cε transcript

American Journal of Respiratory Cell and Molecular Biology

Volumn 21, Issue 6, 1999, Pages 728-737

  Hill, Sandra ^a,b   Herlaar, Ellen ^a   Le Cardinal, Agnès ^a,c   Van Heeke, Gino ^a   Nicklin, Paul ^a  

^a Novartis Institutes for BioMedical Research   (United Kingdom)

^b NOVARTIS HORSHAM RESEARCH CENTRE   (United Kingdom)

^c U de Parasitol Med   (Gabon)

Author keywords

[No Author keywords available]

Indexed keywords

MURINAE;

ANTISENSE OLIGONUCLEOTIDE; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; MESSENGER RNA; RIBONUCLEASE H; STAT6 PROTEIN; STAT6 PROTEIN, HUMAN; STAT6 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL LINE; DOWN REGULATION; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; MOUSE; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-13; INTERLEUKIN-4; MICE; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; RIBONUCLEASE H, CALF THYMUS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 0033257957     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.21.6.3709     Document Type: Article

References (54)

1. Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S. Kashiwamura, K. Nakanishi, N. Yoshida, T. Kishimoto, and S. Akira. 1996. Essential role of Stat6 in IL-4 signaling. Nature 380:627-630.
2. Takeda, K., M. Kamanaka, T. Tanaka, T. Kishimoto, and S. Akira. 1996. Impaired IL-13-mediated functions of macrophages in Stat6-deficient mice. J. Immunol. 157:3220-3222.
3. Shimoda, K., J. van Deursen, M. Y. Sangster, S. R. Sarawar, R. T. Carson, R. A. Tripp, C. Chu, F. W. Quelle, T. Nosaka, D. A. A. Vignali, P. C. Doherty, G. Grosveld, W. E. Paul, and J. N. Ihle. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630-633.
4. Linchan, L. A., W. D. Warren, P. A. Thompson, M. J. Grusby, and M. T. Berton. 1998. Stat6 is required for IL-4-induced germline Ig gene transcription and switch recombination. J. Immunol. 161:302-310.
5. Lin, J. X., T. S. Migone, M. Tsang, M. Friedmann, J. A. Weatherbee, L. Zhou, A. Yamauchi, E. T. Bloom, J. Meitz, S. John, and W. J. Leonard. 1995. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13 and IL-15. Immunity 2:331-339.
6. Zurawski, S. M., P. Chomarat, O. Djossou, C. Bidaud, A. N. J. McKenzie, P. Miossec, J. Banchereau, and G. Zurawski. 1995. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J. Biol. Chem. 270:13869-13878.
7. Callard, R. E., D. J. Mathews, and L. M. Hibbert. 1997. Interleukin 4 and interleukin 13: same response, different receptors. Biochem. Soc. Trans. 25: 451-455.
8. Gauchat, J.-F., D. A. Lebman, R. L. Coffman, H. Gascan, and J. E. de Vries. 1990. Structure and expression of germline epsilon transcripts in human B cells induced by interleukin-4 to switch to IgE production. J. Exp. Med. 172:463-473.
9. Punnonen, J., G. Aversa, B. G. Cocks, A. N. J. McKenzie, S. Menon, G. Zurawski, R. de Waal Malefyt, and J. E. de Vries. 1993. Interleukin-13 induces interleukin-4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA 90:3730-3734.
10. Seder, R. A., and W. E. Paul. 1994. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 12:635-673.
11. Romagnani, S. 1992. Induction of Th1 and Th2 responses: a key role for the "natural" immune response? Immunol. Today 13:379-381.
12. Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227-257.
13. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796-3806.
14. Grünig, G., M. Warnock, A. E. Wakil, R. Venkayya, F. Brombacher, D. M. Rennick, D. Sheppard, M. Mohrs, D. D. Donaldson, R. M. Locksley, and D. B. Corry. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282:2261-2263.
15. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282:2258-2261.
16. Kopf, M., G. Le Gros, M. Bachmann, M. C. Lamers, IL Bluethmann, and G. Köhler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245-248.
17. McKenzie, G., C. L. Emson, S. E. Bell, S. Anderson, P. Fallon, G. Zurawski, R. Murray, R. Grencis, and A. N. J. McKenzie. 1998. Impaired development of Th2 cells in IL-13-deficient mice. Immunity 9:423-432.
18. Kühn, R., K. Rajewsky, and W. Muller. 1991. Generation and analysis of interleukin-4 deficient mice. Science 254:707-710.
19. Haque, S. J., P. Harbor, M. Tabrizi, T. Yi, and B. R. G. Williams. 1998. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4-and IL-13-dependent signal transduction. J. Biol. Chem. 273:33893-33896.
20. Russell, S. M., A. D. Keegan, N. Harada, Y. Nakamura, M. Noguchi, P. Leland, M. C. Friedmann, A. Miyajima, R. K. Puri, W. E. Paul, and W. J. Leonard. 1993. Interleukin-2 receptor γ chain: a functional component of the interleukin-4 receptor. Science 262:1880-1883.
21. O'Shea, J. J. 1997. Jaks, Stats, cytokine signal transduction, and immunoregulation: are we there yet? Immunity 7:1-7.
22. Takeda, K., T. Kishimoto, and S. Akira. 1997. Stat6: its role in interleukin 4-mediated biological functions. J. Mol. Med. 75:317-326.
23. Kaplan, M. H., U. Schindler, S. T. Smiley, and M. J. Grusby. 1996. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 4:313-319.
24. Curiel, R. E., R. Lahesmaa, J. Subleski, M. Cippitelli, R. A. Kirken, H. A. Young, and P. Ghosh. 1997. Identification of a Stat-6-responsive element in the promoter of the human interleukin-4 gene. Eur. J. Immunol. 27: 1982-1987.
25. 2-microglobulin independent and develop normally in the absence of IL-4 priming of T cells. J. Immunol. 160:3299-3304.
26. Kuperman, D., B. Schofield, M. Wills-Karp, and M. J. Grusby. 1998. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyper-responsiveness and mucus production. J. Exp. Med. 187:939-948.
27. Zamecnik, P. C., and M. L. Stephenson. 1978. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc. Natl. Acad. Sci. USA 75:280-284.
28. Stephonson, M. L., and P. C. Zamecnik. 1978. Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide. Proc. Natl. Acad. Sci. USA 75:285-288.
29. Alama, A., F. Barbieri, M. Cagnoli, and G. Schettini. 1997. Antisense oligonucleotides as therapeutic agents. Pharmacol. Res. 36:171-178.
30. Dean, N. M., R. McKay, L. Miraglia, T. Geiger, M. Müller, D. Fabbro, and C. F. Bennett. 1996. Antisense oligonucleotides as inhibitors of signal transduction: development from research tools to therapeutic agents. Biochem. Soc. Trans. 24:623-629.
31. Bennett, C. F., D. Kornbrust, S. Henry, K. Stecker, R. Howard, S. Cooper, S. Dutson, W. Hall, and H. I. Jacoby. 1997. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. J. Pharmacol. Exp. Ther. 280:988-1000.
32. Zhao, Q., J. Temsamani, P. L. Iadarola, Z. Jiang, and S. Agrawal. 1996. Effect of different chemically modified oligodeoxynucleotides on immune stimulation. Biochem. Pharmacol. 51:173-182.
33. Krieg, A. M., S. Matson, and E. Fisher. 1996. Oligodeoxynucleotide modifications determine the magnitude of B cell stimulation by CpG motifs. Antisense Nucleic Acid Drug Dev. 6:133-139.
34. Krieg, A. M. 1998. Immune stimulation by oligonucleotides. In Antisense Research and Application. S. T. Crooke, editor. Springer, Heidelberg. 243-262.
35. Stein, C. A. 1996. Phosphorothioate antisense oligodeoxynucleotides: questions of specificity. Trends Biotechnol. 14:147-149.
36. Crooke, S. T. 1998. Basic principles of antisense therapeutics. In Antisense Research and Application. S. T. Crooke, editor. Springer, Heidelberg. 1-50.
37. Altmann, K.-H., N. M. Dean, D. Fabbro, S. M. Freier, T. Geiger, R. Haener, D. Huesken, P. Martin, B. P. Monia, M. Muller, F. Natt, P. Nicklin, J. Phillips, U. Pieles, H. Sasmor, and H. E. Moser. 1996. Second generation of antisense oligonucleotides: from nuclease resistance to biological efficacy in animals. Chimia 50:168-176.
38. Ichiki, T., W. Takahashi, and T. Watanabe. 1992. The effect of cytokines and mitogens on the induction of Cε germline transcripts in a human Burkitt lymphoma cell line. Int. Immunol. 4:747-754.
39. Shapira, S. K., H. H. Jabara, C. P. Thienes, D. J. Ahern, D. Vercelli, H. J. Gould, and R. S. Geha. 1991. Deletional switch recombination occurs in interleukin-4-induced isotype switching to IgE expression by human B cells. Proc. Natl. Acad. Sci. USA 88:7528-7532.
40. Shapira, S. K., D. Vercelli, H. H. Jabara, S. M. Fu, and R. S. Geha. 1992. Molecular analysis of the induction of immunoglobulin E synthesis in human B cells by interleukin 4 and engagement of CD40 antigen. J. Exp. Med. 175:289-292.
41. Castigli, E., F. W. Alt, L. Davidson, A. Bottaro, E. Mizoguchi, A.K. Bhan, and R. S. Geha. 1994. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Immunology 91: 12135-12139.
42. Gauchat, J. F., G. Aversa., H. Gascan, and J. E. de-Vries. 1992. Modulation of IL-4 induced germline epsilon RNA synthesis in human B cells by tumour necrosis factor-alpha, anti-CD40 monoclonal antibodies or transforming growth factor-beta correlates with levels of IgE production. Int. Immunol. 4: 397-406.
43. Zhou, W., and S. Agrawal. 1998. Mixed-backbone oligonucleotides as second-generation antisense agents with reduced phosphorothioate-related side effects. Bioorg. Med. Chem. Lett. 8:3269-3274.
44. Monia, B. P. 1997. First-and second-generation antisense oligonucleotide inhibitors targeted against human c-raf kinase. Ciba Found. Symp. 209: 107-123.
45. McKay, R. A., L. J. Miraglia, L. L. Cummins, S. R. Owens, H. Sasmor, and N. M. Dean. 1999. Characterisation of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-α expression. J. Biol. Chem. 274:1715-1722.
46. Baker, B. F., S. S. Lot, T. P. Condon, S. Cheng-Flournoy, E. A. Lesnik, H. M. Sasmor, and C. F. Bennett. 1997. 2′-O-(2-melhoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J. Biol Chem. 272:11994-12000.
47. Monia, B. P., H. Sasmor, J. F. Johnston, S. M. Freier, E. A. Lesnik, M. Muller, T. Geiger, K. Altmann, H. Moser, and D. Fabbro. 1996. Sequence-specific antitumour activity of phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo. Proc. Natl. Acad. Sci. USA 93:15481-15484.
48. Lu, B., M. Reichel, D. A. Fisher, J. F. Smith, and P. Rothman. 1997. Identification of a Stat6 domain required for IL-4-induced activation of transcription. J. Immunol. 159:1255-1264.
49. Ichiki, T., W. Takahashi, and T. Watanabe. 1993. Regulation of the expression of human Cε germline transcript. Identification of a novel IL-4 responsive element J. Immunol. 150:5408-5417.
50. Monia, B. P., and N. M. Dean. 1998. Pharmacological activity of antisense oligonucleotides in animal models of disease. In Antisense Research and Application. S. T. Crooke, editor. Springer, Hiedelberg. 427-143.
51. Hutcherson, S. L. 1998. Clinical antiviral activities. In Antisense Research and Application. S. T. Crooke, editor. Springer, Hiedelberg. 445-462.
52. Marwick, C. 1998. First "antisense" drug will treat CMV retinitis. JAMA 280:871.
53. Temsamani, J., and P. Guinot. 1997. Antisense oligonucleotides: a new therapeutic approach. Biotechnol. Appl. Biochem. 26:65-71.
54. Agrawal, S. 1996. Antisense oligonucleotides: towards clinical trials. Trends Biotechnol. 14:376-387.